Quebec Reveals Details Of Biosimilar Switching Policy

Biosimilars Canada Welcomes Initiative As Other Provinces Pursue Similar Schemes

 
• By Akriti Seth

Quebec has revealed further details of its biosimilar switching policy which is expected to generate annual savings of CAD100m by 2022. The move has received support from Biosimilars Canada, as other Canadian provinces pursue similar initiatives. 

Canada Biosimilars
Savings generated from biosimilar switching policy will be reinvested in Quebec’s healthcare system • Source: Alamy

More from Biosimilars

More from Products